Cargando…

Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries

Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceulemans, Michael, Foulon, Veerle, Panchaud, Alice, Winterfeld, Ursula, Pomar, Léo, Lambelet, Valentine, Cleary, Brian, O’Shaughnessy, Fergal, Passier, Anneke, Richardson, Jonathan Luke, Nordeng, Hedvig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835534/
https://www.ncbi.nlm.nih.gov/pubmed/35162405
http://dx.doi.org/10.3390/ijerph19031389
_version_ 1784649457472634880
author Ceulemans, Michael
Foulon, Veerle
Panchaud, Alice
Winterfeld, Ursula
Pomar, Léo
Lambelet, Valentine
Cleary, Brian
O’Shaughnessy, Fergal
Passier, Anneke
Richardson, Jonathan Luke
Nordeng, Hedvig
author_facet Ceulemans, Michael
Foulon, Veerle
Panchaud, Alice
Winterfeld, Ursula
Pomar, Léo
Lambelet, Valentine
Cleary, Brian
O’Shaughnessy, Fergal
Passier, Anneke
Richardson, Jonathan Luke
Nordeng, Hedvig
author_sort Ceulemans, Michael
collection PubMed
description Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medications used by pregnant and breast-feeding women during the first pandemic wave. Factors associated with medication use were estimated by logistic regression. In total, 8378 women participated (i.e., 3666 pregnant and 4712 breastfeeding women). Most responses were collected in Norway (34%) and The Netherlands (28%), followed by Switzerland (19%), Ireland (17%) and UK (2%). Participants were more often professionally active and more often had a higher educational level compared to the general birthing population in each country. Overall, approximately 60% of women reported having used at least 1 medication in the preceding 3 months. Daily and occasional use was reported by 34% and 42% of pregnant and 29% and 44% of breastfeeding women. The most prevalent ATC (Anatomical Therapeutic Chemical) categories were the nervous system, the respiratory system, the alimentary tract/metabolism, and the musculo-skeletal system. Paracetamol, ibuprofen, antacids, and cetirizine were the most frequently used medications. The rate of antibacterial use was lower than previously reported. Having a chronic illness, country, maternal age, SARS-CoV-2 testing, professional status and time since delivery were associated with medication use. In conclusion, perinatal medication use was highly prevalent during the first pandemic wave, underlining the importance of maintaining counseling efforts on medication use, even in times of disrupted healthcare services and/or limited resources.
format Online
Article
Text
id pubmed-8835534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88355342022-02-12 Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries Ceulemans, Michael Foulon, Veerle Panchaud, Alice Winterfeld, Ursula Pomar, Léo Lambelet, Valentine Cleary, Brian O’Shaughnessy, Fergal Passier, Anneke Richardson, Jonathan Luke Nordeng, Hedvig Int J Environ Res Public Health Article Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. Therefore, a cross-sectional study using an anonymous web survey was performed in Ireland, Norway, Switzerland, The Netherlands, and United Kingdom (UK) to investigate the prevalence and type of medications used by pregnant and breast-feeding women during the first pandemic wave. Factors associated with medication use were estimated by logistic regression. In total, 8378 women participated (i.e., 3666 pregnant and 4712 breastfeeding women). Most responses were collected in Norway (34%) and The Netherlands (28%), followed by Switzerland (19%), Ireland (17%) and UK (2%). Participants were more often professionally active and more often had a higher educational level compared to the general birthing population in each country. Overall, approximately 60% of women reported having used at least 1 medication in the preceding 3 months. Daily and occasional use was reported by 34% and 42% of pregnant and 29% and 44% of breastfeeding women. The most prevalent ATC (Anatomical Therapeutic Chemical) categories were the nervous system, the respiratory system, the alimentary tract/metabolism, and the musculo-skeletal system. Paracetamol, ibuprofen, antacids, and cetirizine were the most frequently used medications. The rate of antibacterial use was lower than previously reported. Having a chronic illness, country, maternal age, SARS-CoV-2 testing, professional status and time since delivery were associated with medication use. In conclusion, perinatal medication use was highly prevalent during the first pandemic wave, underlining the importance of maintaining counseling efforts on medication use, even in times of disrupted healthcare services and/or limited resources. MDPI 2022-01-26 /pmc/articles/PMC8835534/ /pubmed/35162405 http://dx.doi.org/10.3390/ijerph19031389 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ceulemans, Michael
Foulon, Veerle
Panchaud, Alice
Winterfeld, Ursula
Pomar, Léo
Lambelet, Valentine
Cleary, Brian
O’Shaughnessy, Fergal
Passier, Anneke
Richardson, Jonathan Luke
Nordeng, Hedvig
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title_full Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title_fullStr Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title_full_unstemmed Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title_short Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries
title_sort self-reported medication use among pregnant and breastfeeding women during the covid-19 pandemic: a cross-sectional study in five european countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835534/
https://www.ncbi.nlm.nih.gov/pubmed/35162405
http://dx.doi.org/10.3390/ijerph19031389
work_keys_str_mv AT ceulemansmichael selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT foulonveerle selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT panchaudalice selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT winterfeldursula selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT pomarleo selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT lambeletvalentine selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT clearybrian selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT oshaughnessyfergal selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT passieranneke selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT richardsonjonathanluke selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries
AT nordenghedvig selfreportedmedicationuseamongpregnantandbreastfeedingwomenduringthecovid19pandemicacrosssectionalstudyinfiveeuropeancountries